ORGANOGENESIS HLD. news, videos and press releases
For more news please use our advanced search feature.
ORGANOGENESIS HLD. - More news...
ORGANOGENESIS HLD. - More news...
- Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
- Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025
- Organogenesis Expands Manufacturing Capacity to Support Future Growth
- Organogenesis Commends Final LCDs
- Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
- Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
- Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
- Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
- Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
- Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
- Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results
- Organogenesis Shares ReNu® Program Update
- Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
- Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference
- Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
- Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
- Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
- Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
- Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
- Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
- Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
- Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results
- Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
- Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS
- Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
- Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance
- Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023
- Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results
- Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors
- Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
